Proven Expertise

Today, with over 175 FDA approvals, Camargo has built an expansive client base across the globe by providing high-quality comprehensive drug development services. Camargo’s team of experts continues to impact and lead this evolving industry by speaking on their areas of expertise at key industry conferences, associations, and webinars.

 

Camargo’s forward thinking and dedicated leadership has established a level of excellence over the years. Satisfying clients globally, while impacting the drug development industry utilizing the niche 505(b)(2) approval pathway, has made Camargo’s expertise widely known within the industry.

 

Camargo continues to teach old dogs new tricks:

 

  • 2-5 pre-IND meetings attained per month with the knowledge and effective communication of former FDA members and industry experts

 

  • Global impact ‒ serving 26 countries, including North America, India, China and Europe

 

  •  95% client referral rate based on excellent service, responsiveness and positive relationships, regulatory and scientific knowledge and overall success rates of regulatory submissions, including the 505(b)(2) approval pathway

 

  • Sought after expertise with 15-20 speaking engagements each year, including key industry conferences, associations and webinars

 

  • Go-to scientific writers on specialized topics, including 505(b)(2) drug development, CMC for 505(b)(2) applications, foreign trial data, DESI drugs, oncology, women’s health and more

 

  • Senior leadership includes a former FDA team leader, who today works as a liaison to effectively communicate with the FDA, ensuring accuracy and speeding time-to-market

 

  • President and CEO, Ken Phelps, recognized by PharmaVOICE as one of the 100 most inspiring people in the life sciences industry